Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool | Zendy

Laurence Cibrelus | Zendy; Clément Lingani | Zendy; Katya C. Fernandez | Zendy; Mamoudou Harouna Djingarey | Zendy; William Perea | Zendy; Stéphane Hugonnet | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool

Author(s) -

Laurence Cibrelus,

Clément Lingani,

Katya C. Fernandez,

Mamoudou Harouna Djingarey,

William Perea,

Stéphane Hugonnet

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ671

Subject(s) - medicine , prioritization , meningococcal vaccine , meningococcal disease , neisseria meningitidis , virology , conjugate , risk assessment , immunization , immunology , antigen , biology , bacteria , genetics , mathematical analysis , mathematics , computer security , management science , economics , computer science

A group A meningococcal (MenA) conjugate vaccine has progressively been introduced in the African meningitis belt since 2010. A country-wide risk assessment tool, the District Prioritization Tool (DPT), was developed to help national stakeholders combine existing data and local expertise to define priority geographical areas where mass vaccination campaigns should be conducted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research